Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;143(5):605-607.
doi: 10.1007/s00401-022-02420-9. Epub 2022 Apr 11.

Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor

Affiliations

Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor

Diane A Flasch et al. Acta Neuropathol. 2022 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Somatic L1 promoter donation drives oncogenic FOXR2 overexpression. a Histology of serial tumor samples. b t-SNE plot comparing genomic DNA methylation profiles of the primary and recurrent tumors to 249 pediatric CNS tumors of 17 types (see Supplementary text, online resource for additional abbreviations). c FOXR2 expression of CNS NBL FOXR2 overlayed by the primary and 2nd recurrent tumors as compared to non-diseased multiple brain regions profiled by GTeX. d Top, schematic of PacBio sequenced L1 insertion with a chr6 transduction sequence (yellow arrow) and flanked by target-site duplication sequence (TSD). Gray numbers match nucleotides of L1.3 consensus sequence. Below, observed tumor transcripts involve L1 splice donor to canonical FOXR2 splice acceptor. e Methylation status of CpG sites (nucleotide numbers) in the L1 5’UTR at the retrotransposed FOXR2 locus (Xp11.21) and the source element (6p24.1) observed in over 90% of bisulfite sequencing reads. f Model of oncogenic activation with chr6 L1 source element (gray ‘L1’ box) insertion in chrX upstream of FOXR2, inducing oncogenic overexpression of FOXR2 (gray and blue squiggles), driving the primary tumor. Recurrent tumor formed, acquiring a TP53 R175H variant (red star)

References

    1. WHO Classification of Tumours Editorial Board (2021) Central nervous system tumours [Internet]. Lyon (France): International Agency for Research on Cancer (WHO classification of tumours series, 5th ed; vol 6). Available from: https://tumourclassification.iarc.who.int/chapters/45. Accessed 9 Mar 2022
    1. Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, et al. LINE-1 retrotransposition activity in human genomes. Cell. 2010;141:1159–1170. doi: 10.1016/j.cell.2010.05.021. - DOI - PMC - PubMed
    1. Belancio VP, Hedges DJ, Deininger P. LINE-1 RNA splicing and influences on mammalian gene expression. Nucleic Acids Res. 2006;34:1512–1521. doi: 10.1093/nar/gkl027. - DOI - PMC - PubMed
    1. Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, Graves T, et al. Mapping and sequencing of structural variation from eight human genomes. Nature. 2008;453:56–64. doi: 10.1038/nature06862. - DOI - PMC - PubMed
    1. Li X, Wang W, Xi Y, Gao M, Tran M, Aziz KE, et al. FOXR2 interacts with MYC to promote its transcriptional activities and tumorigenesis. Cell Rep. 2016;16:487–497. doi: 10.1016/j.celrep.2016.06.004. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances